All Immunology articles – Page 6
-
NewsStudy reveals dual forces driving SARS-CoV-2 evolution: Immune pressure and viral fitness
New research clarifies the complex role of neutralizing antibodies in shaping disease outcomes and the evolution of SARS-CoV-2.
-
NewsA rapid evolutionary process provides Sudanese Copts with resistance to malaria
An international study investigating the genomic diversity of the Sudanese population reveals that the Copts originating in Egypt –who settled in the country between the seventh and eleventh centuries– have acquired a genetic variant that protects them from contracting malaria.
-
NewsA mint idea becomes a game changer for medical devices
Researchers have developed a high‑performance coating made from peppermint essential oil that can be applied to the surfaces of many commonly used medical devices, offering a safer way to protect patients from infection and inflammation.
-
NewsYeast cells can be used for rapid testing of cancer immunotherapy
An international research team has developed a new yeast-based biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before. It can reduce development time for new types of cancer immunotherapy from months to days or weeks.
-
NewsBlood test may give insights into a person’s infection history
Which infections have you already come into contact with? In the future, a simple blood test may be all you need to answer that question. Researchers intend to investigate the sensors the immune system uses to identify pathogens.
-
NewsSugar molecules point to a new weapon against drug-resistant bacteria
Researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognise a sugar found only on bacterial cells – an advance that could underpin a new generation of immunotherapies for multidrug resistant hospital-acquired infections.
-
NewsGut microbe–derived butyrate activates immune cells to enhance vaccine efficacy
Researchers have uncovered a new mechanism showing how butyrate—a short-chain fatty acid produced by gut commensal bacteria—enhances T follicular helper (Tfh) cell activity to promote antibody production and strengthen mucosal vaccine efficacy.
-
NewsResearchers urge focus on child obesity and gut health to reduce risk of diabetes
Researchers are calling for more study of obesity, gut bacteria and metabolic conditions that arise in childhood and adolescence, with an eye to curbing the global rise of type 2 diabetes.
-
NewsScientists demonstrate first-ever single-shot HIV vaccine neutralization success
Scientists have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates.
-
NewsLaunch of clinical trial of investigative nasal spray medicine to prevent illnesses from respiratory viruses
A new clinical trial will test a new experimental intranasal spray designed to boost immune defenses and reduce illness from respiratory viruses.
-
NewsStudy suggests far fewer cervical cancer screenings are needed for HPV‑vaccinated women
In a modeling study of women vaccinated against human papillomavirus (HPV), researchers found that cervical cancer screening could be done far less often than current recommendations without compromising health benefits.
-
NewsGut bacteria may tip the balance between feeding tumors and fueling immunity
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed tumor growth or activate immune cells against the cancer.
-
NewsMetformin shown to prevent Long COVID across risk groups in multiple randomized trials
Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing Long COVID when taken during or shortly after acute infection with SARS-CoV-2.
-
NewsNasal vaccine combats bird flu infection in rodents
Researchers have developed an intranasal H5N1 vaccine that elicited strong immune responses when tested in hamsters and mice and prevented infections in exposed animals. The team also confirmed their vaccine remained effective regardless of prior flu exposure.
-
NewsNew tool shows how to enter and change pneumocystis fungi
Researchers have reported success in genetically modifying the fungal pathogen Pneumocystis murina. Their approach uses extracellular vesicles from mouse lungs to deliver gene-modifying molecules inside the fungal cells. The modified fungus expressed the introduced genomic modifications.
-
NewsFecal microbiota transplantation improves response to immunotherapy in advanced kidney cancer
A new study provides compelling evidence that fecal microbiota transplantation (FMT) can enhance the effectiveness of immunotherapy in patients with advanced metastatic renal cell carcinoma (mRCC).
-
NewsIn rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to one kind of Chikungunya vaccine, which is no longer available in the U.S.
-
NewsPreparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at least two years after a booster vaccination.
-
NewsSerum interleukin-8 can tell pulmonary aspergillosis from bacterial pneumonia in patients with liver failure
Scientists found serum interleukin-8 can be used to differentiate invasive pulmonary aspergillosis from bacterial pneumonia in patients with HBV-associated acute-on-chronic liver failure.
-
NewsCOVID-19 viral fragments shown to target and kill specific immune cells
New research shows that after the body’s defenses kill the virus behind COVID-19, leftover digested chunks of SARS-CoV-2 spike protein can target specific immune cells based on their shape. It could explain why certain populations of cells that detect and fight infection are depleted in patients with severe COVID-19.